Ceridian HCM (CDAY) Tops Q2 EPS by 3c, beats revenue

Ceridian HCM (NYSE: CDAY) reported Q2 EPS of $0.32, $0.03 better than the analyst estimate of $0.29. Revenue for the quarter came in at $365.9 million versus the consensus estimate of $358.23 million.

For earnings history and earnings-related data on Ceridian HCM (CDAY) click here.

You May Also Be Interested In

• SanDisk upgraded at JPMorgan after investor day; shares climb
• Rein Therapeutics Inc. (RNTX) Tops Q2 EPS by 39c
• Acurx Pharmaceuticals (ACXP) Tops Q2 EPS by 4c